Serum CEA and CA 15-3 as prognostic factors in primary breast cancer

British Journal of Cancer

Volumn 86, Issue 8, 2002, Pages 1217-1222

  Ebeling, F G ^a   Stieber, P ^a   Untch, M ^a   Nagel, D ^a   Konecny, G E ^a   Schmitt, U M ^a   Fateh Moghadam, A ^a   Seidel, D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CA 15 3; CEA; Multivariate analysis; Primary breast cancer; Prognosis; Tumour markers

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HORMONE RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0037156936     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600248     Document Type: Article

References (33)

1. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer
2. The histologic grading of cancer
3. Relationship of tumorsize, lymph node status, and survival in 24,740 breast cancer cases
4. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis
5. Survival from first recurrence: Relative importance of prognostic factors in 1.015 breast cancer patients
6. Regression models and life-tables
7. CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer
8. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients
9. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
10. The tumour associated antigen CA 15.3 in primary breast cancer. Evaluation in 667 cases
11. MCA and CA 15-3 in der verlaufskontrolle bei patientinnen mit mammakarzinom
12. Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer
13. Nonparametric estimation from incomplete observations
14. Role of blood markers in the detection of metasases from primary breast cancer
15. Serum marker combinations in human breast cancer
16. Tissue and plasma carcinoembryonic antigen in early breast cancer: A prognostic factor
17. Prognostic factors in early breast carcinoma
18. Prognostic factors and treatment decisions in axillary-node-negative breast cancer
19. Carcinoembryonic antigen in breast cancer
20. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer: A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the study group of the Japanese Breast Cancer Society on hormone receptors and prognosis in breast cancer
21. A prospective evaluation of CA 15-3 in Stage I carcinoma of the breast
22. Objective measurement of therapeutic response in breast cancer using tumor markers
23. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer
24. Time-varying prognostic impact of tumor biological factors urokinase (uPA), PAI1 and steroide hormone receptor status in primary breast cancer
25. Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma
26. Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma
27. Möglicher einsatz der tumormarker in der nachsorge
28. Carcinoembryonic antigen expression in Stages I and II breast cancer: Its relationship with clinicopathologic factors
29. Comparison of CA 15-3 and carcinoembrionic antigen in monitoring the clinical course of patients with metastatic breast cancer
30. Circulating tumor markers in breast cancer
31. Clinical correlation between CEA and breast cancer
32. CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse